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Introduction
Isolated pulmonary valve stenosis (PS) makes up 6-9% of all 
congenital heart defects among children. PS is divided into val-
var, subvalvar, supravalvar, according to the anatomically stenot-
ic portion, and valvar PS is known to be the most common 
type. The type of stenosis may be the deciding point for the 
method of therapy, surgical or interventional, and its effects.1) 
PS can be divided into mild, moderate, and severe accord-
ing to the pressure gradient between the systemic pressure 
and the right ventricle systolic pressure (RVSP): mild to mod-
erate (RVSP ≤ 75% of systemic pressure); severe (RVSP 76-
100% of systemic pressure); critical (RVSP > 100%). In the 
past, these patients were candidates of surgical valvotomy, but 
in moderate to severe PS, percutaneous balloon pulmonary 
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Background: Isolated pulmonary valve stenosis (PS) makes up 6-9% of all congenital heart defects among children. The 
initial gold standard for diagnosis, follow-up of PS is by echocardiography. However, the most accurate diagnosis still remains to 
be measurement of the pressure gradient through transcatheterization. The purpose of this study is to compare the difference 
between the echocardiographic data to the cardiac catheterization data on the diagnosis, treatment, and follow-up in patients 
diagnosed as PS, and to see what parameters should be closely monitored.
Methods: A total of 112 patients (Male : Female = 46 : 66) who underwent balloon pulmonary valvuloplasty (BPV) at 
Severance Cardiovascular Hospital, between December, 2002 to August, 2012 were retrospectively analyzed. The patients were 
all under 16 years of age and critical PS patients who underwent BPV were excluded from this study.
Results: The pre-BPV right ventricle (RV)-pulmonary artery (PA) systolic pressure gradient and post-BPV systolic pressure 
gradient showed statistically significant decrease. The pre-BPV RV-PA systolic pressure gradient and 3 month post-BPV systolic 
pressure gradient showed statistically significant decrease. The consistency between the echocardiographic data and cardiac 
catheterization data shows statistically significant consistency. The mean pressure gradient and systolic pressure gradient on the 
echocardiography shows high consistency when comparing with the cardiac catheterization data.
Conclusion: Our study shows that BPV in PS is a safe and effective procedure in children and adolescent. The standard 
echocardiographic evaluation of PS, during diagnosis and follow-up, should include mean transpulmonic pressure gradient, as 
well as the peak systolic pressure gradient. The success of the procedure should be held off until at least 3 months, only if the 
patients do not show any symptoms.
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valvuloplasty (BPV) has risen as the first treatment option 
since the first introduction in 1982.2)
Since the initial adoption of the procedure, equipment for 
BPV has improved and the skills of the performers have ame-
liorated, leading to minimal complications and its usefulness, 
proven in many previous studies.3-5)
The initial gold standard for diagnosis of PS is by echocar-
diography. In 2-dimensional (2D) echocardiography there can 
be evidence of right ventricle (RV) hypertrophy, RV enlarge-
ment, or right atrial enlargement. Color flow Doppler imaging 
demonstrates high-velocity turbulent systolic flow through the 
pulmonary valve.6) Pressure gradients can simultaneously be es-
timated by continuous wave Doppler.7) Pressure gradients con-
sist of echocardiographic systolic pressure gradient and mean 
pressure gradient. In case of aortic valve stenosis which is similar 
obstruction disease, mean pressure gradient is considered more 
important for evaluation of disease among those two gradients.8) 
However, the most accurate diagnosis still remains to be mea-
surement of the pressure gradient through transcatheterization.
The purpose of this study is to compare the difference be-
tween the echocardiographic data to the cardiac catheteriza-
tion data on the diagnosis, treatment, and follow-up in pa-




A total of 112 patients (Male : Female = 46 : 66) who un-
derwent BPV at Severance Cardiovascular Hospital, between 
December, 2002 to August, 2012 were retrospectively ana-
lyzed. The patients were all under 16 years of age and critical 
PS patients who underwent BPV were excluded from this 
study. The age range was between 1 month to 192 months 
and mean age 38.35 months (± 48.55 months). Patients with 
concomitant simple observable heart diseases such as atrial 
septal defect or patent foramen ovale were included, but those 
with complex heart diseases were excluded. On retrospective 
review of the medical files, the main parameters investigated 
were, age, sex, concomitant diseases, baseline RV and pulmo-
nary artery (PA) pressure gradient measured during catheter-
ization, remaining residual pressure gradient measured during 
catheterization, pulmonary valve annulus size, balloon size, 
and minor and major complications. 
The type of PS was diagnosed using the 2D echocardiogra-
phy and the severity was measured using the Doppler echo-
cardiographic measurement assessed by modified Bernoulli 
equation. Echocardiography datas were collected from ram-
domized results, using our center modality, Philips IE 33 
(Philips Andover, Andover, MA, USA), GE vivid E9 (GE 
Healthcare, Fairfield, CT, USA), The Siemens Acuson sequoia 
512 (Siemens Germany, North Rhine-Westphalia, Germany). 
Parasternal short axis view is mainly used for evaluation of PS, 
and additional view was performed, when it was nessacery. 
The peak-to-peak pressure gradient difference between the 
RV and the PA was measured, as well as the mean transpul-
monic pressure gradient. When the gradient on echocardiog-
raphy was greater than 40 mmHg, or the estimated right ven-
tricular pressure was greater than 50 mmHg, patients who 
have exertional dyspnea, angina, syncope, or presyncope and 
RV-PA peak-to-peak gradient greater than 30 mmHg at cathe-
terization, BPV was indicated.9)10) During the transcatheter 
procedure, the pre-procedural measurement between the RV 
and PA was measured and the post-procedural measurement 
was also measured, to decide the success of the procedure. We 
considered the procedure successful when the pressure gradi-
ent was less than 20 mmHg.  
Follow-up echocardiography was performed within 24 hours 
of the procedure, 1 week, 3 months, 6 months, and yearly 
thereafter.  
Parametric data were entered into a Microsoft Excel 2007 
spreadsheet (Microsoft, Redmond, WA, USA). Results are 
presented as mean ± standard deviation or numbers and per-
centages and analyzed using MedCalc ver 12.3.0.0 (MedCalc 
Software, Ostend, Belgium). 
Results
Subjects
The mean age of the patients were 38.35 months (± 48.55 
months) and they ranged from 1 month to 192 months (16 
years old), the median age was 17 months. Of the 112 total 
patients, there were 46 male patients (41.07%) and 66 female 
patients (58.92%). 
Patients with concomitant simple observable heart diseases 
consisted of 32 patients. They were 29 atrial septal defect pa-
tients (25.9%), 2 ventricluar septal defect patients (1.8%), 3 
patent ductus arteriosus patients (2.7%) and 3 patent foramen 
ovale patients (2.7%).  
The mean follow-up duration of the patient was 30.64 
months (± 26.84 months) ranging from 3 months to 108 
months (median, 24 months) (Table 1).
Adverse events
There were no noted major complications. Two cases (1.79%) 
of minor complications were detected, both of which were 
spiking fever, but both subsided after a day (Table 1).
Echocardiographic data 
The type of diagnosed PS were 85 valvular PS (75.9%), 8 su-
pravalvular PS (7%), 17 supravalvular and valvular PS (15.5%), 
and 2 valvular and subvalvular PS (1.79%) (Table 1). BPV was 
performed on 8 supravalvular valvular PS patients who showed 
combined valvular PS on catheterization. The mean pressure gra-
dient measured on pre-BPV echocardiogram between RV-PA 
was 38.76 mmHg (± 16.91 mmHg), ranging from 11 mmHg 
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to 108 mmHg, and the median was 37 mmHg. The mean pres-
sure gradient measured on echocardiogram within 24 hours 
post-BPV was 21.33 mmHg (± 42.09 mmHg), ranging from 0 
mmHg to 73.5 mmHg, and the median was 17.8 mmHg.  
The mean pressure difference between the pre-BPV and 
post-BPV was 17.02 mmHg (± 14.39 mmHg), ranging from 
0 mmHg to 83 mmHg.
The echocardiographic data of pre-BPV RV-PA systolic 
pressure gradient, 24 hour post-BPV RV-PA systolic pressure 
gradient, 1 week post-BPV, and 3 months post-BPV was also 
analyzed (Fig. 1).  
This figure shows the statistical analysis of mean, maximum 
and minimum results and degree of distribution of variables, 
indicating the statistical significance of each variables. The 
pre-BPV RV-PA systolic pressure gradient and post-BPV sys-
tolic pressure gradient showed statistically significant decrease, 
but the difference of 24 hour post-BPV systolic pressure gra-
dient and 1 week post-BPV systolic pressure gradient was not 
statistically significant. However, the pre-BPV RV-PA systolic 
pressure gradient and 3 month post-BPV systolic pressure 
gradient showed statistically significant decrease. On follow-
ups, there were 87 patients (77.7%) among 112 patients whose 
pressure gradient declined over 20 mmHg because of success-
ful procedure, and 25 patients (22.3%) had pressure gradient 
over 20 mmHg without any symptoms, so the additional pro-
cedure was required.
This shows that echocardiography measuring the RV-PA 
systolic pressure gradient should be regularly followed-up, 
since the RV-PA systolic pressure gradient shows gradual de-
crease after the procedure, and the success of the procedure 
should be determined after at least 3 months, which shows 
statistically significant decrease in our data.  
Hemodynamic data
The mean RV-PA pressure gradient on cardiac catheteriza-
tion before BPV was 39.11 mmHg (± 16.99 mmHg), the 
range was between 15 mmHg to 110 mmHg, and the medi-
an was 35 mmHg. The mean RV-PA pressure gradient on 
cardiac catheterization after BPV was 14.14 mmHg (± 14.14 
mmHg), the range was between 0 mmHg to 60 mmHg, and 
the median was 10 mmHg.  
The mean pressure difference on cardiac catheterization be-
fore and after BPV was 24.75 mmHg (± 34.77 mmHg), the 
range was between 2 mmHg to 80 mmHg, and the median 
was 20 mmHg.  
The mean pulmonary valve annulus size was 13.93 mm (± 
4.94 mm), the range was between 6.5 mm to 31 mm, and the 
median was 13 mm. The mean balloon size used during the 
procedure was 17.5 mm (± 5.6 mm), the range was between 7 
mm to 30 mm, and the median was 16.5 mm. The mean bal-
loon size to pulmonary valve annulus ratio was 1.28 (± 0.24), 
the range was between 0.67 to 2.25, and the median was 1.25.  
We compared the difference between the RV-PA systolic 
pressure gradient before and after BPV on echocardiography 
against the difference between the RV-PA systolic pressure 
gradient before and after BPV on cardiac catheterization (Ta-
Table 1. The clinical data of patients with pulmonary valve stenosis
Characteristics Value (n = 112)
Male, n (%)      46 (41.07)
Female, n (%)                        66 (58.92)
Age at procedure (mo)   38.35 ± 48.55
Follow-up duration (mo) 31.09 ± 24.0
Complication, n (%)      2 (1.79)
Type of pulmonary stenosis, n (%)
    Valvular    85 (75.9)
    Supravalvular 8 (7)
    Valvular & supravalvular    17 (15.5)
    Valvular & infundibular      2 (1.79)
PV annulus (mm) 13.93 ± 4.94 
Ballon size (mm) 17.5 ± 5.6 
Balloon size/PV annulus   1.27 ± 0.25
Values are presented as number (%) or mean ± SD. PV: pulmonary valve
Fig. 1. The echocardiographic RV-PA systolic pressure gradient during 
follow-up. Pre-BPV RV-PA systolic pressure gradient (pre), 1 day 
following (post) after BPV, 1 week follow-up (1 week), 3 month follow-up 
(3 month). Note significant reduction (p < 0.001) after BPV which 
remains unchanged [p > 0.1 (0.23)] at 1 week. However, at long term 
follow-up there was further fall (p < 0.001). RV: right ventricle, PA: 





























g) p < 0.001 
p < 0.001 p > 0.1 p < 0.001 
Table 2. The echocardiographic RV-PA systolic pressure gradient 
during follow-up 
Variable (n = 112) Intraclass correlation coefficient(-1 < ICC ≤ 1) 
Change in echo data vs. change 
  in cath data 
0.69-0.82 
Change in echo data: the difference in the RV-PA systolic pressure gradient 
pre-BPV to RV-PA systolic pressure gradient 24 hour post-BPV on 
echocardiography, Change in cath data: the difference in the RV-PA systolic 
pressure gradient pre-BPV to RV-PA systolic pressure gradient post-BPV on 
cardiac catheterization. ICC: the consistency is higher if the value approaches 
1, and the consistency is lower if the value approaches -1, BPV: percutaneous 
balloon pulmonary valvuloplasty, RV: right ventricle, PA: pulmonary artery
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ble 2). Intraclass correlation coefficient was used to compare 
the consistency of two variables, the measurement is calculat-
ed from minimum -1 to maximum 1. As the result gets closer 
to 1, more consistent measurement can be obtained. If the re-
sult is over 0.5, this means the result is the highly consist val-
ue. The consistency between the echocardiographic data and 
cardiac catheterization data was 0.69-0.82, which shows that 
the decrease in the pressure difference between both data 
shows statistically significant consistency.  
Table 3 and 4 show the consistency between the cardiac 
catheterization pressure gradient to the echocardiographic sys-
tolic pressure gradient, and the cardiac catheterization pres-
sure gradient to the echocardiographic mean transpulmonic 
pressure gradient. Among 112 patients, 76 patients were en-
rolled who were able to obtain both parameters. In the pre-
BPV data, the intraclass correlation coefficient was 0.79-0.88 
in the analysis between the cardiac catheterization data to 
echocardiographic systolic pressure gradient, which shows rel-
atively higher consistency than the intraclass correlation coef-
ficient (0.55-0.71) between the cardiac catheterization data to 
echocardiographic mean transpulmonic pressure gradient. 
However, both values show high consistency, overall.  
Table 4 shows the post-BPV analysis. The intraclass correla-
tion coefficient was 0.57-0.73 in the analysis between the car-
diac catheterization data to the echocardiographic systolic 
pressure gradient, which shows relatively lower consistency 
than the intraclass correlation coefficient (0.61-0.76) between 
the cardiac catheterization data to echocardiographic mean 
transpulmonic pressure gradient. However, the values show 
high consistency, overall. This shows that the mean pressure 
gradient and systolic pressure gradient on the echocardiogra-
phy shows high consistency when comparing with the cardiac 
catheterization data, but the consistency between the mean 
transpulmonic pressure gradient on the echocardiography was 
relatively higher after the procedure, which necessitates mea-
surement of mean transpulmonic pressure gradient during 
echocardiographic follow-up after the procedure.  
Discussion
Congenital pulmonary stenosis is a progressive defect, which 
needs adequate treatment in different periods of life. The deci-
sion on the type of treatment should be made, according to 
the degree of hemodynamic changes and symptoms of the pa-
tient. Regular follow-up and very early detection of changes is 
important. Even in mild or moderate disease very fast progres-
sion in infancy or early childhood has been documented.11)12) 
Patients with severe stenosis should undergo treatment even if 
it is well tolerated and is asymptomatic at the beginning, be-
cause of the possibility of dangerous complication.13)14)
Echocardiography plays an essential role in the diagnosis 
and follow-up of patients with PS. Our main purpose of this 
study was to see how much the echocardiographic data and 
the actual hemodynamic data coincide, and to see whether the 
measured systolic pressure gradient or the mean pressure gra-
dient shows higher consistency. In aortic valve stenosis (AS) 
patients, the mean transaortic pressure gradient, along with 
the peak pressure gradient, has taken its place in the standard 
echocardiographic evaluation. The mean transaortic pressure 
gradient has been known to show higher consistency than the 
systolic peak pressure gradient in reflecting the severity, and it 
has been known to be relatively accurate measurement during 
follow-up.15) Because PS and AS fall in the similar obstructive 
heart disease group, we tried to apply the same concept in PS 
patients as AS patients.  
In this study, the success of BPV was clearly evident in our 
data, both on the echocardiographic data and the cardiac cath-
eterization data, which shows the efficacy of BPV in the treat-
ment of PS. The pressure decrease was statistically significant, 
similar to those data that have been proven in many other lit-
eratures.2)16-18) Also, in our data, the RV-PA systolic pressure 
gradient and the mean transpulmonic pressure gradient on 
the echocardiography showed high consistency to the invasive, 
but accurate cardiac catheterization data, which indicates that 
echocardiographic data is a reliable and efficient method in 
the diagnosis and follow-up of patients with PS, before and af-
ter the procedure.  
The RV-PA systolic pressure gradient and mean transpul-
monic pressure gradient both showed a high consistency to 
the cardiac catheterization data. However, the pre-BPV data 
showed relatively higher consistency between the echocardio-
graphic RV-PA systolic pressure gradient to cardiac catheter-
ization data, and the post-BPV data showed relatively higher 
Table 4. The comparison between post-BPV cardiac catheterization 
data to both echocardiographic RV-PA mean pressure gradient and 
RV-PA systolic pressure gradient
Variable (n = 76) Intraclass correlation coefficient(-1 < ICC ≤ 1) 
Post systolic pressure gradient 
  -post BPV RV-PA pressure gradient
0.61-0.76 
Post mean pressure gradient
  -post BPV RV-PA pressure gradient
0.57-0.73 
BPV: percutaneous balloon pulmonary valvuloplasty, ICC: the consistency 
is higher if the value approaches 1, and the consistency is lower if the value 
approaches -1, RV: right ventricle, PA: pulmonary artery
Table 3. The comparison between pre-BPV cardiac catheterization 
data to both echocardiographic RV-PA mean pressure gradient and 
RV-PA systolic pressure gradient
Variable (n = 76) Intraclass correlation coefficient(-1 < ICC ≤ 1) 
Pre systolic pressure gradient 
  -pre BPV RV-PA pressure gradient
0.79-0.88 
Pre mean pressure gradient 
  -pre BPV RV-PA pressure gradient
0.55-0.71 
ICC: the consistency is higher if the value approaches 1, and the consistency 
is lower if the value approaches -1, BPV: percutaneous balloon pulmonary 
valvuloplasty, RV: right ventricle, PA: pulmonary artery
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consistency between the echocardiographic mean transpul-
monic pressure gradient to cardiac catheterization data, which 
indicates the need to measure both RV-PA systolic pressure 
gradient and mean transpulmonic pressure gradient, during 
diagnosis as well as during follow-up.  
During the follow-up of patients with PS after BPV, the 
pressure gradient showed gradual decrease, when comparing 
the echocardiography performed after 24 hours, 1 week, and 3 
months. As long as the patients do not show any noteworthy 
symptoms, the success of the procedure or the need of re-BPV 
should be delayed until at least 3 months after the procedure, 
in the mild to severe PS patients. 
In conclusion, our study shows that BPV in PS is a safe and 
effective procedure in children and adolescent. The standard 
echocardiographic evaluation of PS, during diagnosis and fol-
low-up, should include mean transpulmonic pressure gradi-
ent, as well as the peak systolic pressure gradient. The success 
of the procedure should be held off until at least 3 months, 
only if the patients do not show any symptoms.  
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